2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theNeurodegenerative Disorder Therapeutics Market from 2025 to 2034?
The increasing prevalence of neurodegenerative diseases, particularly among the aging population, is driving the growth of the neurodegenerative disorder therapeutics market. The number of people over 60 is expected to reach 2.1 billion by 2050, with a significant increase in those aged 80 and above. For instance, in 2024, the Alzheimer’s Association estimated that 5.8 million Americans suffer from Alzheimer’s disease, with numbers expected to rise to 14 million by 2050. This rising prevalence is fueling demand for treatments, thereby propelling the neurodegenerative disorder therapeutics market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp
#What Long-Term Growth Rate is Expected for theNeurodegenerative Disorder Therapeutics Market Between 2025 and 2034?
The neurodegenerative disorder therapeutics market size has grown strongly in recent years. It will grow from $18.53 billion in 2024 to $20.04 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth is driven by an aging population, rising prevalence of neurodegenerative disorders, increasing life expectancy, and greater investments from pharmaceutical companies in research.
The neurodegenerative disorder therapeutics market is expected to grow strongly, reaching $28.33 billion by 2029, with a CAGR of 9.0%. The growth is attributed to rising demand for personalized medicine, targeted therapies, increasing clinical trial availability, and growing healthcare expenditure. Major trends include disease-modifying therapies, non-pharmacological interventions, digital health solutions, and biomarker-driven trials.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2818
Which Upcoming Market Trends and Innovations Are Set to Influence theNeurodegenerative Disorder Therapeutics Market’s Path Forward?
Companies in the neurodegenerative disorder therapeutics market are forming strategic alliances to accelerate the development of treatments for diseases like Parkinson’s and motor neuron disease. For example, NRG Therapeutics partnered with Domainex in July 2022 to create novel small-molecule medications for these conditions.
Which Key Market Players Are Shaping the Future and Growth of theNeurodegenerative Disorder Therapeutics Market?
Major companies operating in the neurodegenerative disorder therapeutics market include Biogen Inc., Pfizer Inc., Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB S.A., F. Hoffmann-La Roche Ltd., ACADIA Pharmaceuticals Inc., H. Lundbeck A/S, Boehringer Ingelheim International GmbH, Merck Serono S.A., Orion Corporation, Mitsubishi Tanabe Pharma America, Allergan PLC, GlaxoSmithKline PLC, AbbVie Inc., Eli Lilly and Company, Celgene Corporation, Neuro-Hitech Inc., Bayer Schering Pharma AG, Amarin Corporation PLC, AstraZeneca plc, Alector Inc., Yumanity Therapeutics Inc., Yangtze River Pharmaceutical Group Co. Ltd., Chongqing Zein Pharmaceutical Co. Ltd., Eisai Co. Ltd., Bristol Myers Squibb Company, AB Science S.A., Amylyx Pharmaceuticals Inc., Genentech Inc., GenSight Biologics S.A., AC Immune SA, Annexon Bioscience Inc., BioArctic Neuroscience AB, Cajal Neuroscience Inc., Cognito Therapeutics Inc., Grifols S.A., New Equilibrium Biosciences Inc., Prothena Corporation PLC, Tessera Therapeutics Inc., Vigil Neuroscience Inc.
What Are the Core Segments of the Neurodegenerative Disorder Therapeutics Market, and How Do They Contribute to Growth?
The neurodegenerative disorder therapeutics market covered in this report is segmented –
1) By Indication Type: Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Parkinson’s Disease: Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics
2) By Alzheimer’s Disease: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Anti-Amyloid Monoclonal Antibodies
3) By Multiple Sclerosis: Immunomodulators, Immunosuppressants, Corticosteroids
4) By Huntington’s Disease: Tetrabenazine, Antipsychotic Medications
5) By Other Indication Types: Amyotrophic Lateral Sclerosis (ALS) Treatments, Frontotemporal Dementia Treatments, Prion Disease Treatments
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=2818&type=smp
What Regions Are Dominating the Neurodegenerative Disorder Therapeutics Market Growth?
The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Browse Through More Reports Similar to the Global Neurodegenerative Disorder Therapeutics Market 2025, By The Business Research Company:
Neurosurgery Devices And Equipment Global Market Report 2024
Neurology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Brain And Neuroimaging Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
